Over the years, this treatment have been presented by the doctors for its high durability, long lasting and comfortable nature. Basically such oral implants are tiny insertions which are produced from biocompatible items. These materials are surgically inserted in the jawbone of the patient’s mouth to support the damaged teeth. These biocompatible components are made of various sizes and shapes, which are chosen and utilized by the medical practitioner according to the requirement of the patient.Highlights: Second quarter contract revenue of $85.2 million, a 39 percent increase from 2014 Adjusted contract margins of 26 percent Second quarter altered diluted EPS of $0.22, including a $0.05 reduction in EPS from royalties in today’s quarter Operating cashflow of $16 million We are very pleased to present another strong financial one fourth, with all our divisions attaining excellent results, said William S. Marth, AMRI's president and chief executive officer. Notably, latest acquisitions, combined with cost reduction initiatives and efficiency initiatives we've designed to date, are adding to continued strong contract margin performance.